Thu, 03/06/2025 - 22:17 |
Shockwave Medical Launches Novel Forward Intravascular Lithotripsy Platform in U.S. to Transform Treatment of Difficult-to-Cross Calcified Lesions |
Johnson and Johnson |
Sat, 01/11/2025 - 02:45 |
Boston Scientific Announces Agreement to Acquire Bolt Medical, Inc. |
Boston Scientific |
Mon, 05/13/2024 - 17:39 |
One-Year Results of the DETOUR2 Trial published in the Journal of Vascular Surgery (JVS) |
Endologix |
Mon, 03/04/2024 - 18:54 |
BD Initiates International Study to Expand Treatment Options for Patients with Peripheral Arterial Disease |
bd |
Thu, 02/29/2024 - 14:28 |
Endologix Initiates Percutaneous Transmural Arterial Bypass (PTAB)1 Post-Market Study |
Endologix |
Thu, 08/11/2022 - 21:16 |
Vascular experts establish Appropriate Use of Intravascular Ultrasound (IVUS) in peripheral interventions |
Philips |
Thu, 08/04/2022 - 07:46 |
Endologix Receives CE Mark Certification under EU-MDR for AFX2 Endovascular AAA System |
Endologix |
Fri, 07/29/2022 - 08:12 |
Geisinger vascular laboratories earn testing reaccreditation |
Geisinger Healt... |
Mon, 06/13/2022 - 08:05 |
Philips announces positive three-year clinical research results from its Tack Optimized Balloon Angioplasty (TOBA) II below-the-knee (BTK) clinical trial |
Philips |
Wed, 01/05/2022 - 07:03 |
Cardiovascular risks may be worse for thinking, memory skills in middle-aged women |
Mayo Clinic |
Mon, 11/22/2021 - 23:59 |
Endologix Announces Completion of Enrollment in the TORUS 2 Study for PAD in SFA |
Endologix |
Tue, 11/16/2021 - 10:24 |
Ryflumen, First Peripheral High-Pressure Balloon Dilatation Catheter of Endovastec, Approved for Marketing by NMPA |
MicroPort |
Thu, 11/11/2021 - 15:13 |
Vflower, First Venous Stent System by MicroPort Endovastec, Gains Access to Chinas Special Approval Procedure for Innovative Medical Devices |
MicroPort |
Wed, 11/10/2021 - 00:56 |
Endologix Names Dr. Matthew Thompson President and CEO |
Endologix |
Mon, 10/18/2021 - 13:49 |
First U.S. Patient Treated Following FDA Approval of Cook Medicals First-of-its-Kind Zilver PTX Drug-Eluting Peripheral Sten |
Cook Medical |
Wed, 10/06/2021 - 05:48 |
Boston Scientific Eluvia Drug-Eluting Vascular Stent System Exhibits Superiority Compared to Bare Metal Stents |
Boston Scientif... |
Tue, 10/05/2021 - 13:24 |
Clinical experts establish first-ever global consensus for the appropriate use of intravascular ultrasound (IVUS) in peripheral vascular disease interventions |
Philips |
Wed, 09/22/2021 - 03:43 |
Naturally occurring protein to block inflammatory response improved stroke recovery in mice |
American Heart ... |
Thu, 06/03/2021 - 12:15 |
Two-year data from the TOBA II BTK clinical trial demonstrate durability of dissection repair below the knee with the Philips Tack Endovascular System |
Philips |
Mon, 05/17/2021 - 09:07 |
ELEGANCE Patient Registry Focuses on Women and People of Color to Address Inequities in the Treatment of Peripheral Artery Disease |
Boston Scientif... |
Wed, 04/28/2021 - 04:34 |
The perfect picture of in-home care |
Spectrum Health |
Tue, 04/20/2021 - 16:21 |
Five-year patient-level meta-analysis of ILLUMENATE EU RCT and Pivotal study results confirms safety profile of Philips Stellarex .035 low-dose Drug-Coated Balloon |
Philips |
Mon, 04/12/2021 - 18:39 |
Endologix LLC Announces Acquisition of PQ Bypass, Inc. |
Endologix |
Wed, 03/31/2021 - 16:02 |
Research Story Tip: Study: Doctors Overusing Costly, Riskier Method for Clearing Clogged or Blocked Vessels |
Johns Hopkins H... |
Sun, 01/24/2021 - 18:56 |
Five-year ILLUMENATE EU RCT and Pivotal study results confirm safety profile of Philips Stellarex .035 low-dose drug-coated balloon |
Philips |